eli lilly retatrutide press release 2024 2025 Lilly's three-pronged drug puts obesity field 'on notice' Lilly's triple agonist delivers up

Cerebral perfusion alterations in type 2 diabetes mellitus - A systematic review

[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Kadouh H., Chedid V., Halawi H., Burton D.D., Clark M.M., Khemani D., Vella A., Acosta A., Camilleri M

Unlike stimulant-based weight loss drugs, GLP-1 works with your body's existing biology rather than forcing artificial energy depletion, which is why side effects tend to be manageable and often decrease over time

Tirzepatide is a dual GIP and GLP-1 receptor agonist and the active ingredient in FDA-approved medications such as Mounjaro and Zepbound

Stay Hydrated Adequate water intake throughout the day supports gut motility and may ease bloating

Lower glucagon levels also contribute to a lower overall appetite